These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 6148936)
1. Dopamine stimulated glycosylation of brain proteins in vitro is inhibited only partially by dopamine receptor antagonists. Lössner B; Jork R; Lindner M; Lucke B; Matthies H Biomed Biochim Acta; 1984; 43(6):775-87. PubMed ID: 6148936 [TBL] [Abstract][Full Text] [Related]
2. Dopamine-stimulated fucosylation of brain proteins in vitro is not inhibited by puromycin. Lössner B; Linke I; Eppendorfer B; Jork R Biomed Biochim Acta; 1985; 44(3):465-73. PubMed ID: 2988525 [TBL] [Abstract][Full Text] [Related]
3. The effect of dopamine on L-fucose incorporation into hippocampal and striatal slices of dopamine-supersensitive rats. Honza R; Jork R; Lössner B; Matthies H Biomed Biochim Acta; 1983; 42(4):419-22. PubMed ID: 6684921 [TBL] [Abstract][Full Text] [Related]
4. Methylglucamine orotate does not affect dopamine-stimulated fucosylation of rat hippocampal proteins. Pchalek V; Lössner B; Matthies H Biomed Biochim Acta; 1988; 47(9):843-8. PubMed ID: 3248122 [TBL] [Abstract][Full Text] [Related]
5. Dopamine stimulated L-fucose incorporation into brain proteins is related to an increase in fucokinase activity. Jork R; Schmitt M; Lössner B; Matthies H Biomed Biochim Acta; 1984; 43(3):261-70. PubMed ID: 6331424 [TBL] [Abstract][Full Text] [Related]
6. Dopamine stimulated fucosylation of rat hippocampal proteins in vitro. A histoautoradiographic study. Pohle W; Lössner B; Pchalek V Biomed Biochim Acta; 1985; 44(4):527-35. PubMed ID: 4026811 [TBL] [Abstract][Full Text] [Related]
7. [5-HT1A/1B receptors, alpha2-adrenoceptors and the post-receptor adenylate cyclase activation in the mice brain are involved in the antidepressant-like action of agmatine]. Jiang XZ; Li YF; Zhang YZ; Chen HX; Li J; Wang NP Yao Xue Xue Bao; 2008 May; 43(5):467-73. PubMed ID: 18717332 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary. Enjalbert A; Bockaert J Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429 [TBL] [Abstract][Full Text] [Related]
9. Catecholaminergic activation of G-protein coupling in rat spinal cord: further evidence for the existence of dopamine and noradrenaline receptors in spinal grey and white matter. Venugopalan VV; Ghali Z; Sénécal J; Reader TA; Descarries L Brain Res; 2006 Jan; 1070(1):90-100. PubMed ID: 16423330 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of dopamine on Ca(2+)-calmodulin-dependent protein kinase II activity in rat hippocampal slices. Hou XY; Zhang GY Zhongguo Yao Li Xue Bao; 1999 Oct; 20(10):902-6. PubMed ID: 11270989 [TBL] [Abstract][Full Text] [Related]
11. Role of calmodulin-dependent phosphorylation in chronic sulpiride-induced striatal dopamine receptor supersensitivity. Lau YS; Runice C; Dowd F J Pharmacol Exp Ther; 1984 Apr; 229(1):32-7. PubMed ID: 6323689 [TBL] [Abstract][Full Text] [Related]
12. Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: possible implications for the regulatory role of D2 receptors. Schoffelmeer AN; Hogenboom F; Mulder AH; Ronken E; Stoof JC; Drukarch B Synapse; 1994 Jul; 17(3):190-5. PubMed ID: 7974202 [TBL] [Abstract][Full Text] [Related]
13. Stimulation of dopamine receptors inhibited Ca2+-calmodulin-dependent protein kinase II activity in rat striatal slices. Hou XY; Tang FM; Zhang GY Acta Pharmacol Sin; 2001 Nov; 22(11):966-70. PubMed ID: 11749784 [TBL] [Abstract][Full Text] [Related]
14. Expression and pharmacological characterization of the human D3 dopamine receptor. Freedman SB; Patel S; Marwood R; Emms F; Seabrook GR; Knowles MR; McAllister G J Pharmacol Exp Ther; 1994 Jan; 268(1):417-26. PubMed ID: 8301582 [TBL] [Abstract][Full Text] [Related]
15. Effect of D1- and D2-dopamine agonists on neocortical and hippocampal EEG activity of rat brain: modulation of rimcazole effect. Verma A; Kulkarni SK; Nayar U Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):515-25. PubMed ID: 7905945 [TBL] [Abstract][Full Text] [Related]
16. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum. Capasso A; Sorrentino L Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209 [TBL] [Abstract][Full Text] [Related]
17. Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats. Gobert A; Lejeune F; Rivet JM; Audinot V; Newman-Tancredi A; Millan MJ J Pharmacol Exp Ther; 1995 Jun; 273(3):1032-46. PubMed ID: 7791073 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterisation of the thermogenic effect of bupropion. Liu YL; Connoley IP; Heal DJ; Stock MJ Eur J Pharmacol; 2004 Sep; 498(1-3):219-25. PubMed ID: 15363998 [TBL] [Abstract][Full Text] [Related]
19. [Dopamine-stimulated glycosylation of rat hippocampal proteins in vitro: structure-response relationship]. Pchalek V; Lössner B; Matthies H Biomed Biochim Acta; 1985; 44(11-12):1651-8. PubMed ID: 4091838 [TBL] [Abstract][Full Text] [Related]
20. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity. Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]